Matching clinical trials with patients: Global patient search and identification using de-identified EHRs
Clinical Trials and Pharmacovigilance
September 23-24, 2019 | Prague, Czech Republic
Baris Erdogan
Clinerion, Turkey
Keynote : J Clin Res Pharm
Abstract:
Background: Patient recruitment for clinical trials is a wellknown
problem that has been extensively documented.
Challenges in patient recruitment are the most prominent
reason for clinical trial delays. Such delays have a knockon
effect on the entire drug development process, costing
pharma companies lost sales revenues. Beyond financial
considerations, delays also result in avoidable suffering of
patients. These challenges can be overcome by introducing
a technology-assisted process for finding patients who could
benefit from inclusion in a clinical trial.
Objective: We propose a technology-assisted process
for finding de-identified patients who could benefit from
inclusion in a clinical trial; this process accelerates recruitment,
the most prominent reason for trial delays, which result in
avoidable suffering of patients and cost pharma companies’
sales revenues.
Method: We implemented a system compatible with hospital
information systems which performs real-time, Big Data
analytics on de-identified electronic medical records from
connected hospitals. The system can perform data-assisted
protocol optimization to speed up the protocol development
process, site feasibility evaluation to improve site strategy
(fewer sites with more patients) and searches the EHR for
potentially eligible patients for clinical trials and allows
authorized research staff to reidentify them for recruitment.
Results: The system is operational in more than 100 healthcare
institutions in 16 countries. We present three example cases
which demonstrate the system’s primary benefits during the
critical patient recruitment phase:
1. Rescue study: recruitment for an ongoing dyslipidemia trial
was behind schedule and stalled at one-third of the required
numbers; with the system, recruitment was completed within
6 weeks after screening of 15% of the system’s proposed
candidates.
2. Faster recruitment: recruitment for an atherosclerosis trial
was completed 6 months ahead of schedule
3. Efficient recruitment: in several trials the pool of identified
and potentially eligible patients consistently exceeded the
investigators’ expectations by 10-30 times.
Conclusion: The electronic“patient network explorer” system
addresses the critical bottleneck of slow patient recruitment.
The system enables search and identification of suitable
clinical trial candidates using the electronic records of multiple
hospitals – in real time. The system has been shown to find 10-
30x more patients than traditional methods. As the system uses
de-identified patient data, patient privacy is also preserved.
Biography:
Barış Erdoğan is the country manager of Clinerion, Turkey. He studied computer engineering at the Middle East Technical University and holds M.Sc. and Ph.D. in educational technology. His expertise and experience include management of innovative medical informatics projects and implementation of end-to-end healthcare IT enterprise information systems, both in the public and private sectors.
E-mail: paix30@hotmail.com
PDF HTML